Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging

Movement Disorders

Volumn 26, Issue 4, 2011, Pages 713-718

  Cho, Zang Hee ^a   Oh, Se Hong ^a   Kim, Jong Min ^b   Park, Sung Yeon ^a   Kwon, Dae Hyuk ^a   Jeong, Hye Jin ^a   Kim, Young Bo ^a   Chi, Je Geun ^a,b   Park, Chan Woong ^a   Huston, John ^c   Lee, Kendall H ^d   Jeon, Beom S ^b  

^a Gachon University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c MAYO CLINIC   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

7.0T MRI; Brain imaging; Neurodegenerative disorder; Parkinson's disease; Substantia nigra

Indexed keywords

ADULT; AGED; ARTICLE; CEREBRAL PEDUNCLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IN VIVO STUDY; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA PARS COMPACTA; UNIFIED PARKINSON DISEASE RATING SCALE;

ADULT; AGED; BRAIN MAPPING; CASE-CONTROL STUDIES; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 79955012377     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23465     Document Type: Article

References (22)

1. Bjorklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci 2007; 30: 194-202.
2. Hornykiewicz O, Kish SJ. Biochemical pathophysiology of Parkinson's disease. Adv Neurol 1987; 45: 19-34.
3. Riederer P, Wuketich S. Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm 1976; 38: 277-301.
4. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998; 339: 1044-1053.
5. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
6. Meara J, Bhowmick BK, Hobson P. Accuracy of diagnosis in patients with presumed Parkinson's disease. Age Ageing 1999; 28: 99-102.
7. DeKosky ST, Marek K. Looking backward to move forward: early detection of neurodegenerative disorders. Science 2003; 302: 830-834.
8. Rojas GM, Raff U, Quintana JC, Huete I, Hutchinson M. Image fusion in neuroradiology: three clinical examples including MRI of Parkinson disease. Comput Med Imaging Graph 2007; 31: 17-27.
9. Hutchinson M, Raff U. Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra. J Neurol Neurosurg Psychiatry 1999; 67: 815-818.
10. Hutchinson M, Raff U. Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. AJNR Am J Neuroradiol 2000; 21: 697-701.
11. Minati L, Grisoli M, Carella F, De Simone T, Bruzzone MG, Savoiardo M. Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging. AJNR Am J Neuroradiol 2007; 28: 309-313.
12. Graham JM, Paley MN, Grunewald RA, Hoggard N, Griffiths PD. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 2000; 123(Pt 12): 2423-2431.
13. Adachi M, Hosoya T, Haku T, Yamaguchi K, Kawanami T. Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. AJNR Am J Neuroradiol. 1999; 20: 1500-1506.
14. Haacke EM, Ayaz M, Khan A, et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging. 2007; 26: 256-264.
15. Abduljalil AM, Schmalbrock P, Novak V, Chakeres DW. Enhanced gray and white matter contrast of phase susceptibility-weighted images in ultra-high-field magnetic resonance imaging. J Magn Reson Imaging 2003; 18: 284-290.
16. Duyn JH, van Gelderen P, Li TQ, de Zwart JA, Koretsky AP, Fukunaga M. High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci U S A 2007; 104: 11796-11801.
17. Fischl B, Wald LL. Phase maps reveal cortical architecture. Proc Natl Acad Sci U S A 2007; 104: 11513-11514.
18. Cho ZH, Kim YB, Han JY, et al. New brain atlas-mapping the human brain in-vivo with 7.0T MRI and comparison with postmortem histology. Int J Imaging Systems Technol 2008; 18: 2-8.
19. Cho ZH, Han JY, Hwang SI, et al. Quantitative analysis of the hippocampus using images obtained from 7.0T MRI. Neuroimage 2010; 49: 2134-2140.
20. Cho ZH, Min HK, Oh SH, et al. Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging. J Neurosurg 2010; 113: 639-647.
21. Chen Z, Johnston LA, Kwon DH, Oh SH, Cho ZH, Egan GF. An optimised framework for reconstructing and processing MR phase images. Neuroimage 2010; 49: 1289-1300.
22. Oikawa H, Sasaki M, Tamakawa Y, Ehara S, Tohyama K. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol 2002; 23: 1747-1756.